These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30887496)

  • 1. Patient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone.
    Cook A; Boesch S; Heck S; Brunt E; Klockgether T; Schöls L; Schulz A; Giunti P
    Acta Neurol Scand; 2019 Jun; 139(6):533-539. PubMed ID: 30887496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idebenone in Friedreich's ataxia.
    Tonon C; Lodi R
    Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Friedreich's ataxia: idebenone treatment in early stage patients.
    Artuch R; Aracil A; Mas A; Colomé C; Rissech M; Monrós E; Pineda M
    Neuropediatrics; 2002 Aug; 33(4):190-3. PubMed ID: 12368988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study.
    Meier T; Perlman SL; Rummey C; Coppard NJ; Lynch DR
    J Neurol; 2012 Feb; 259(2):284-91. PubMed ID: 21779958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH; Schulz JB; Giunti P
    J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
    Lynch DR; Perlman SL; Meier T
    Arch Neurol; 2010 Aug; 67(8):941-7. PubMed ID: 20697044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma idebenone monitoring in Friedreich's ataxia patients during a long-term follow-up.
    Paredes-Fuentes AJ; Cesar S; Montero R; Latre C; Genovès J; Martorell L; Cuadras D; Colom H; Pineda M; Del Mar O'Callaghan M; Sarquella-Brugada G; Darling A; Artuch R
    Biomed Pharmacother; 2021 Nov; 143():112143. PubMed ID: 34507114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
    Cooper JM; Schapira AH
    Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.
    Rustin P; von Kleist-Retzow JC; Chantrel-Groussard K; Sidi D; Munnich A; Rötig A
    Lancet; 1999 Aug; 354(9177):477-9. PubMed ID: 10465173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia.
    Drinkard BE; Keyser RE; Paul SM; Arena R; Plehn JF; Yanovski JA; Di Prospero NA
    Arch Phys Med Rehabil; 2010 Jul; 91(7):1044-50. PubMed ID: 20599042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007791. PubMed ID: 19821439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
    Velasco-Sánchez D; Aracil A; Montero R; Mas A; Jiménez L; O'Callaghan M; Tondo M; Capdevila A; Blanch J; Artuch R; Pineda M
    Cerebellum; 2011 Mar; 10(1):1-8. PubMed ID: 20865357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial.
    Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M; Pascual-Pascual SI
    Cerebellum; 2013 Oct; 12(5):713-20. PubMed ID: 23625326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
    Hausse AO; Aggoun Y; Bonnet D; Sidi D; Munnich A; Rötig A; Rustin P
    Heart; 2002 Apr; 87(4):346-9. PubMed ID: 11907009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.
    Rustin P; Rötig A; Munnich A; Sidi D
    Free Radic Res; 2002 Apr; 36(4):467-9. PubMed ID: 12069112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurophysiological evaluation in children with Friedreich's ataxia.
    Sival DA; du Marchie Sarvaas GJ; Brouwer OF; Uges DR; Verschuuren-Bemelmans CC; Maurits NM; Brunt ER; van der Hoeven JH
    Early Hum Dev; 2009 Oct; 85(10):647-51. PubMed ID: 19775837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
    Lodi R; Rajagopalan B; Bradley JL; Taylor DJ; Crilley JG; Hart PE; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Free Radic Res; 2002 Apr; 36(4):461-6. PubMed ID: 12069111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial.
    Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M
    Acta Neurol Scand; 2014 Jan; 129(1):32-40. PubMed ID: 23668357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.